SA89 Neuromodulation With Transcranial Direct Current Stimulation (tDCS) Reduces Impulsivity

was 37% during PQ, 37% during Q, 36% during POQ, and 34% PC, and for hydroxychloroquine 31% during PQ, 32% during Q, 32% during POQ, and 30% PC.For the two most used biological drugs, utilization for adalimumab was 14% during PQ, 14% during Q, 14% during POQ, and 13% PC, and for etanercept 12% during PQ, 12% during Q, 11% during POQ, and 10% PC.Conclusions: We found that use of conventional and biologic drugs for RA were hardly affected by COVID-19 when assessing patient treatment patterns in secondary data sources.Potential biases associated with the reduction in available patients during Q compared to PQ, POQ, and PC requires attention in future studies.